PT-141 10MG

Description

PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (alpha-MSH). It is structurally related to Melanotan II but differs at the C-terminus, where a hydroxyl group replaces the amide, producing a compound with distinct receptor subtype preferences within the melanocortin family.

Research Context

Preclinical investigations have studied PT-141 as a melanocortin receptor agonist with research interest in its relative activity at MC4R and MC3R subtypes. Laboratory studies have examined the compound in central nervous system signaling models, including hypothalamic and limbic-system receptor characterization. Researchers have also used PT-141 in comparative structure-activity studies alongside other alpha-MSH analogs to examine how C-terminal modifications affect receptor selectivity and signaling profile. The compound is frequently cited in the broader melanocortin research literature as a pharmacological tool for distinguishing MC4R-mediated effects from those of other receptor subtypes.

Reconstitution & Storage

• Recommended reconstitution: 2-3 mL bacteriostatic water per 10 mg vial
• Storage: Lyophilized: 2-8°C (refrigerated), long-term -20°C. Reconstituted: 2-8°C, use within 28 days.
• Stability: Avoid freeze-thaw cycles. Protect from light.

Quality Specifications

Research Use Only Disclaimer

This product is sold strictly for laboratory and scientific research purposes. Not for human consumption, ingestion, or administration. Not intended to diagnose, treat, cure, or prevent any disease. Not approved by the FDA for any clinical use.